EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The ethics of risk-stratified cancer screening

Rebecca A Dennison, Juliet A Usher-Smith, Stephen D John

European Journal of Cancer · 2023-07 · 187 · 1-6

DOI: 10.1016/j.ejca.2023.03.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023-07. Verfasst von Rebecca A Dennison und 2 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK. Electronic address: rl423@medschl.ca…. Hauptthemen laut MEDLINE: Early Detection of Cancer, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer screening programmes aim to save lives and reduce cancer burden through prevention or early detection of specific cancers. Risk stratification, where one or more elements of a screening programme are systematically tailored based on multiple individual-level risk factors, could improve the balance of screening benefits and harms and programme efficiency. In this article, we explore the resulting ethical issues and how they impact risk-stratified screening policymaking using Beauchamp and Childress's principles of medical ethics. First, in line with universal screening programme principles, we acknowledge that risk-stratified screening should be introduced only when the expected total benefits outweigh the harms, and where it has a favourable overall impact compared to alternative options. We then discuss how these are difficult to both value and quantify, and that risk models typically perform differently in sub-populations. Second, we consider whether screening is an individual right and whether it is fair to offer more or less intensive screening to some and not others based on personal characteristics. Third, we discuss the need to maintain respect for autonomy, including ensuring informed consent and considering the screening implications for those who cannot or choose not to participate in the risk assessment. In summary, from an ethical perspective, focusing on population-level effectiveness alone is insufficient when planning risk-stratified screening programmes and the range of ethical principles must be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerNeoplasmsHumansEthics, MedicalRisk AssessmentInformed ConsentMass Screening

Stichwörter der Autor:innen

Cancer screeningEthicsHealth policyPersonalised medicineRisk factors

Autor:innen und Institutionen

  • Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK. Electronic address: rl423@medschl.cam.ac.uk.
  • Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
  • Department of History and Philosophy of Science, University of Cambridge, Cambridge CB2 3RH, UK.

Zitieren

APA

Dennison, R. A., Usher-Smith, J. A., & John, S. D. (2023). The ethics of risk-stratified cancer screening. European Journal of Cancer, 187, 1-6. https://doi.org/10.1016/j.ejca.2023.03.023

Vancouver

Dennison RA, Usher-Smith JA, John SD. The ethics of risk-stratified cancer screening. European Journal of Cancer. 2023;187:1-6. doi:10.1016/j.ejca.2023.03.023

BibTeX
@article{Dennison2023,
  author = {Dennison, Rebecca A and Usher-Smith, Juliet A and John, Stephen D},
  title = {The ethics of risk-stratified cancer screening},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {187},
  pages = {1--6},
  doi = {10.1016/j.ejca.2023.03.023}
}
Kostenlos starten →